Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study was terminated prematurely after 2 years because during to the COVID-19 pandemic, the face-to-face mode of administration of the interviews in the General Adult Population Sample was not feasible.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.
The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Germany and in adult IQOS users registered in the IQOS user database of Philip Morris GmbH (Germany IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| General Population | Adults living in Germany. |
| |
| IQOS Users | Adult current IQOS users (at the time of survey) living in Germany who are registered in the Germany IQOS User Database and agreed to be contacted for research purposes at the time of registration. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Survey on Use of Tobacco Products in the General Population | Other | Face-to-face survey to estimate the prevalence of current tobacco use status in the general population of Germany. |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of current tobacco use | Prevalence of current tobacco use status in the study population. | Study duration (3 years). |
| Past tobacco use status | Past tobacco use status (cigarette, IQOS and other innovative products) in the study population. | Study duration (3 years). |
| Self-reported health status | Association between self-reported health status and use of tobacco products in the study population. | Study duration (3 years). |
| Perceived risk | Association between patterns of use with perceived risk. | Study duration (3 years). |
| IQOS use experience | Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits). | Study duration (3 years). |
Not provided
Not provided
Inclusion Criteria (all participants, including IQOS users):
Inclusion Criteria (IQOS users only):
Exclusion Criteria:
Not provided
Not provided
Not provided
The study population will be limited to residents of Germany.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pierpaolo Magnani | Philip Morris Products S.A. | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Philip Morris Products S.A. | Lausanne | Canton of Vaud | 1007 | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D064424 | Tobacco Use |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
| Survey on Use of Tobacco Products in IQOS Users | Other | Online survey to describe patterns of use in adult IQOS users residing in Germany. |
|